Activated protein C inhibits amyloid β production via promoting expression of ADAM-10

Brain Research

Volumn 1545, Issue , 2014, Pages 35-44

  Li, Bing ^a   Yu, Dawei ^b   Xu, Zhiying ^b  

^a QINGDAO UNIVERSITY   (China)

^b YANTAISHAN HOSPITAL   (China)

Author keywords

Activated protein C; ADAM 10; Alzheimer's disease; Amyloid beta; APP processing

Indexed keywords

ACTIVATED PROTEIN C; ADAM10 ENDOPEPTIDASE; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; CTF ALPHA PROTEIN; CTF BETA PROTEIN; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; DRUG EFFECT; IN VITRO STUDY; MEMORY DISORDER; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; TG2576 MOUSE;

MUS;

ACTIVATED PROTEIN C; ADAM-10; ALZHEIMER'S DISEASE; AMYLOID BETA; APP PROCESSING;

ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTICOAGULANTS; DISEASE MODELS, ANIMAL; HUMANS; INSULYSIN; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEPRILYSIN; PROTEIN C;

EID: 84892591154     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.12.005     Document Type: Article

References (40)

1. R.A. Adams, M. Passino, B.D. Sachs, T. Nuriel, and K. Akassoglou Fibrin mechanisms and functions in nervous system pathology Mol. Interv. 4 2004 163 176
2. M. Asai, C. Hattori, B. Szabó, N. Sasagawa, N. Sasagawa, K. Maruyama, S. Tanuma, and S. Ishiura Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase Biochem. Biophys. Res. Commun. 301 2003 231 235
3. E. Buoso, C. Lanni, G. Schettini, S. Govoni, and M. Racchi beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain Pharmacol. Res 2010 62308 62317
4. T. Cheng, D. Liu, J.H. Griffin, J.A. Fernández, F. Castellino, and E.D. Rosen et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective Nat. Med. 9 3 2003 338 342
5. R. Deane, B. LaRue, A.P. Sagare, F.J. Castellino, Z. Zhong, and B.V. Zlokovic Endothelial protein C receptor- assisted transport of activated protein C across the mouse blood-brain barrier J. Cereb. Blood Flow Metab. 29 2009 25 33
6. F.S. Esch, P.S. Keim, E.C. Beattie, R.W. Blacher, A.R. Culwell, T. Oltersdorf, D. McClure, and P.J. Ward Cleavage of amyloid beta peptide during constitutive processing of its precursor Science 248 1990 1122 1124
7. J.H. Finigan, S.M. Dudek, P.A. Singleton, E.T. Chiang, J.R. Jacobson, S.M. Camp, S.Q. Ye, and J.G. Garcia Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation J. Biol. Chem. 280 2005 17286 17293
8. K. Genc Activated protein C: therapeutic implications for Alzheimer's disease Med. Hypotheses 69 2007 701 702
9. A.K. Ghosh, S. Gemma, and J. Tang Beta-secretase as a therapeutic target for Alzheimer's disease Neurotherapeutics 5 2008 399 408
10. T.E. Golde The Abeta hypothesis: leading us to rationally designed therapeutic strategies for the treatment or prevention of Alzheimer disease Brain Pathol. 15 2005 84 87
11. J.H. Grifin, J.A. Fernandez, L.O. Mosnier, D. Liu, T. Cheng, and H. Guo et al. The promise of protein C Blood Cell Mol. Dis. 36 2006 211 216
12. H. Guo, H. Gelbard, T. Cheng, R. Insalaco, J.A. Fernández, J.H. Griffin, and B.V. Zlokovic Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3 Neuron 41 2004 563 572
13. M.H. Han, S.I. Hwang, D.B. Roy, D.H. Lundgren, J.V. Price, S.S. Ousman, G.H. Fernald, B. Gerlitz, W.H. Robinson, S.E. Baranzini, B.W. Grinnell, C.S. Raine, R.A. Sobel, D.K. Han, and L. Steinman Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets Nature 451 2008 1076 1081
14. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
15. A. Jamsa, O. Belda, M. Edlund, and E. Lindström BACE-1 inhibition prevents the gamma-secretase inhibitor evoked Abeta rise in human neuroblastoma SH-SY5Y cells J. Biomed. Sci. 18 2011 76
16. D.E. Joyce, L. Gelbert, A. Ciaccia, B. DeHoff, and B.W. Grinnell Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis J. Biol. Chem. 276 2001 11199 11203
17. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discovery 10 2011 698 712
18. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
19. J. Milano, J. McKay, and C. Dagenais et al. Modulation of notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation Toxicol. Sci 82 1 2004 341 358
20. J.S. Miners, N. Barua, and P.G. Kehoe et al. Love S. Aβ-degrading enzymes: potential for treatment of Alzheimer disease J. Neuropathol. Exp. Neurol. 70 2011 944 959
21. L.O. Mosnier, B.V. Zlokovic, and J.H. Griffin The cytoprotective protein C pathway Blood 109 2007 3161 3172
22. N.N. Nalivaeva, C. Beckett, N.D. Belyaev, and A.J. Turner Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120 2012 167 185
23. G. Periz, and M.E. Fortini Proteolysis in Alzheimer's disease. Can plasmin tip the balance? EMBO Rep. 1 2000 477 478
24. M. Riewald, R.J. Petrovan, A. Donner, B. DeHoff, and B.W. Grinnell Activation of endothelial cell protease activated receptor 1 by the protein C pathway Science 296 2002 1880 1882
25. E.D. Roberson, and L. Mucke 100 years and counting: prospects for defeating Alzheimer's disease Science 314 2006 781 784
26. T. Sakamoto, H. Ogawa, K. Takazoe, M. Yoshimura, H. Shimomura, Y. Moriyama, H. Arai, and K. Okajima Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin J. Am. Coll. Cardiol. 42 2003 1389 1394
27. S. Singh, A.S. Kushwah, R. Singh, M. Farswan, and R. Kaur Current therapeutic strategy in Alzheimer's disease Eur. Rev. Med. Pharmacol. Sci 16 2012 1651 1664
28. B. Sheng, K. Gong, and Y. Niu Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: implications for the treatment of Alzheimer's disease Free Radical Biol. Med 46 2009 1362 1375
29. B.g. Sheng, X. Wang, B. Su, H.G. Lee, G. Casadesus, G. Perry, and X. Zhu Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease J. Neurochem 120 2012 419 429
30. B. Solomon, and D. Frenkel Immunotherapy for Alzheimer's disease Neuropharmacology 59 2010 303 309
31. T. Tomita, and T. Iwatsubo γ-Secretase as a therapeutic target for treatment of Alzheimer's disease Curr. Pharm. Des 12 2006 661 670
32. M. Van Oijen, J.C. Witteman, A. Hofman, P.J. Koudstaal, and M.M. Breteler Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia Stroke 36 2005 2637 2641
33. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, and M. Citron Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
34. V. Vingtdeux, and P. Marambaud Identification and biology of α-secretase J. Neurochem 120 Suppl. 1 2012 34 45
35. Y.J. Wang, H.D. Zhou, and X.F. Zhou Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives Drug Discovery Today 11 2006 931 938
36. C.T. Walker, A.H. Marky, A.L. Petraglia, T. Ali, N Chow, and B.V. Zlokovic Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact Brain Res. 2010 1347 2010 125 131
37. B.V. Zlokovic Neurovascular mechanisms of Alzheimer's neurodegeneration Trend Neurosci. 28 2005 202 208
38. B.V. Zlokovic, and J.H. Griffin Cytoprotective protein C pathways and implications for stroke and neurological disorders Trends Neurosci 34 4 2011 198 209
39. B.V. Zlokovic, C. Zhang, D. Liu, J. Fernandez, J.H. Griffin, and M. Chopp Functional recovery after embolic stroke in rodents by activated protein C Ann. Neurol. 58 2005 474 477
40. Z. Zhong, H. Ilieva, L. Hallagan, R. Bell, I. Singh, N. Paquette, M. Thiyagarajan, R. Deane, J.A. Fernandez, S. Lane, A.B. Zlokovic, T. Liu, J.H. Griffin, N. Chow, F.J. Castellino, K. Stojanovic, D.W. Cleveland, and B.V. Zlokovic Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells J. Clin. Invest. 119 2009 3437 3449